Urine Biomarkers Predict Kidney Function Recovery After Ambulatory Acute Kidney Injury in Blood Pressure Treatment

MedXY Editorial Team•Oct 2, 2025•Clinical Updates

Urine biomarkers measured during ambulatory acute kidney injury (AKI) are associated with subsequent kidney function recovery in hypertensive adults undergoing blood pressure treatment.
Higher urine albumin-to-creatinine ratio and lower epidermal growth factor (EGF) levels predict nonrecovery of eGFR under standard blood pressure treatment.
In intensive blood pressure treatment, higher urine α-1 microglobulin and lower EGF and kidney injury molecule-1 (KIM-1) levels are linked to nonrecovery.
Urine biomarker profiles may help distinguish which patients experiencing serum creatinine elevations will have persistent kidney dysfunction, guiding management strategies.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Urine biomarkers measured during ambulatory acute kidney injury (AKI) are associated with subsequent kidney function recovery in hypertensive adults undergoing blood pressure treatment.
Higher urine albumin-to-creatinine ratio and lower epidermal growth factor (EGF) levels predict nonrecovery of eGFR under standard blood pressure treatment.
In intensive blood pressure treatment, higher urine α-1 microglobulin and lower EGF and kidney injury molecule-1 (KIM-1) levels are linked to nonrecovery.
Urine biomarker profiles may help distinguish which patients experiencing serum creatinine elevations will have persistent kidney dysfunction, guiding management strategies.